![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Leo Pharma A/s Ballerup Dk, based in Denmark, is a pharmaceutical company.
One of their significant offerings is Fusidic acid, Micronised, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-040 - Rev 01
This Chemical Type CEP, issued on January 19, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 798 associated with this CEP further emphasizes